2019
DOI: 10.1097/qad.0000000000002157
|View full text |Cite
|
Sign up to set email alerts
|

Postzone phenomenon resulting in a false-negative cerebral spinal fluid cryptococcal antigen lateral flow assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(16 citation statements)
references
References 9 publications
0
16
0
Order By: Relevance
“…In addition, it is worth cautioning that a negative test does not exclude the possibility of cryptococcal infection; and false-negative reactions may be attributed to other interfering factors (eg, post-zone phenomenon, also known as the ‘hook’ effect, the presence of immunocomplexes preventing release of glucuronoxylomannan antigen) or in cats with localized disease. 2 , 3 , 16 , 26 , 39 , 40 In the case presented herein, the manufacturer of the Meridian Premier Cryptococcal Antigen EIA test kit initiated an urgent voluntary medical device recall of three test kit lots between 17 December 2018 through 30 April 2020 (United States Food and Drug Administration Class 2 Device Recall: PREMIER Cryptococcal Antigen enzyme immunoassay [Recall number. Z-0732-2019], lot numbers: 602096K089, 602096K090, 602096K091).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, it is worth cautioning that a negative test does not exclude the possibility of cryptococcal infection; and false-negative reactions may be attributed to other interfering factors (eg, post-zone phenomenon, also known as the ‘hook’ effect, the presence of immunocomplexes preventing release of glucuronoxylomannan antigen) or in cats with localized disease. 2 , 3 , 16 , 26 , 39 , 40 In the case presented herein, the manufacturer of the Meridian Premier Cryptococcal Antigen EIA test kit initiated an urgent voluntary medical device recall of three test kit lots between 17 December 2018 through 30 April 2020 (United States Food and Drug Administration Class 2 Device Recall: PREMIER Cryptococcal Antigen enzyme immunoassay [Recall number. Z-0732-2019], lot numbers: 602096K089, 602096K090, 602096K091).…”
Section: Discussionmentioning
confidence: 99%
“…Case Reports in Infectious Diseases inflammation-induced vasospasms, and thrombosis presenting as lacunar infarctions often in the thalamus, internal capsule, basal ganglia, and rarely the brainstem, as occurred in this patient [19]. e LFA, LA, and EIA have been shown to have sensitivities and specificities as high as 100% in detecting cryptococcal antigen in the CSF [20].…”
mentioning
confidence: 53%
“…A complication of chronic cerebral meningitis is lacunar cerebral infarctions. Infection can lead to vasculitis, inflammation-induced vasospasms, and thrombosis presenting as lacunar infarctions often in the thalamus, internal capsule, basal ganglia, and rarely the brainstem, as occurred in this patient [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Six were in the CSF and in HIV-infected patients. [15][16][17][18] However, the only specimens tested were CSF. A retrospective study of patients with culture-confirmed CM showed that the CrAg LFA had 100% sensitivity in the serum.…”
Section: Discussionmentioning
confidence: 99%